Adaptive Kinase Signaling Enables Escape from Small-Molecule Inhibition in Glioblastoma
Mike van Heumen, Linde Hoosemans, Jolanda A. F. Piepers, Sander S. Rensen, Kim Rosalie Kampen, Ann Hoeben, Marc Vooijs
This study identifies compensatory pathway activation as a mechanism of resistance to single-agent small-molecule inhibitors in glioblastoma and shows that combination therapy can overcome this resistance.
bioRxiv · Oct 28, 2025 · PreprintCancer Biology